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6.13%, pregnancy 5.57% and nervous system diseases 3.45%.
These groups of deseases are, by importance, the main cause of
absence from work in all the regions. The rate of sick leaves over
30 days for the entire territory of the Republic of Serbia is
7.06%. The point of interest here is that this rate is very uneven
in varous regions and amounts from 1.72% to 18.27%. The
total liabilities of RHII in the period from January to September
2005, for reimbursement of sick leaves were €56,732,175. CON-
CLUSIONS: Data obtained by this analysis illustrate that the
sick leave rate is very high and uneven, which is the result of
absence of medical doctrine standards for evaluation of tempo-
rary work disability. In addition, the most frequent reasons for
sick leaves are the effects of bad habits, poverty and risk factors:
smoking, lack of physical activity, overweight and generally poor
life quality and insufﬁcient protection at work by employers.
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OBJECTIVE: To analyze the price changes in the leading thera-
peutic groups and medicines after the introduction of the new
pricing schema in Serbia. METHODS: The legislative analysis of
the new pricing schema was applied on price changes. The
leading 10 medicines by therapeutic classes both in ﬁnancial
terms were chosen on the basis of the previous market analysis.
The relative share of price changes and waged price indexes were
calculated. RESULT: In 2005 the Ministry Council has issued the
new drug prices regulation that changes the pricing approach
from “cost+” to reference pricing. Italy, Croatia and Slovenia
were chosen for reference countries and prices have been com-
pared at wholesale level on the basis of different discounting per-
centages matching the local interest rate. The manufacturers
should provide a set of documents including pharmacoeconomic
analysis in free form for new price registration. The goal of the
pharmacoeconomic analysis should be to evaluate the impact of
the new price on the affordability. The market analysis revealed
that the leading ATC groups in ﬁnancial terms are cardiovascu-
lar medicines (C), anti infective (J), acting on muscles and bones
and anxiolytics (N) accounting for near 30% of the whole
market. After the introduction of the new pricing schema the
leading medicines in those ATC groups changed their character-
istics—group C quantities prescribed and total cost increased by
10,86% and 21,08% respectively; group J reduced quantity by
15,50% and increased value by 19,02%, group M reduce quan-
tity by 15,46% and total cost by 99, 40% and anxiolytic
increased quantity and total cost by 8,08% and 63,75% respec-
tively. CONCLUSION: New pricing schema lead to the increas-
ing usage of the most important medicines in value terms but has
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OBJECTIVES: To allocate an annual budget (2006) for each
primary care health team (PHCT) in relation to pharmaceutical
expenditure. METHODS: Three factors are considered in the
allocation formula: A capitation factor: allocation for insured
population based on real average costs per capita of the
autonomous community (7 million people) considering 20
isocost age bands. Pearson’s variation coefﬁcient was applied to
deﬁne isocost bands (criteria: PCV < 10% in each band). Gender
is also considered in this indirect standardization process. This
allocation value is increased by the monetary ﬂows generated by
not-assigned insured (other PHCT, other autonomous commu-
nities and foreigners) and subtracted by the pharmaceutical cost
service lent to their own insured population in other PHCT. This
capitation factor is increased in the coefﬁcient of global growth
expenditure established for 2006 (4%). Modulator factor con-
siders the number of old people’s homes managed, the variation
of insured population during last year and the value of the rate
of use (Pearson’s correlation coefﬁcient between standardised
expenditure per inhabitant and the rate of use is 53% (p < 0.05)).
Finally an adjustment factor is applied in order to establish a
temporal horizon. Three PHCT groups (33–66 percentiles) are
deﬁned according to deviations in relation to real expenditure
for 2005 (normal distribution: p > 0.1 in Z-Kolmogorov
Smirnov). For every group a minimum and maximum increase
is determined, maintaining the order and the global increase
established for all the PHCTs (4%). RESULTS: considering pop-
ulation structure for each PHCT makes possible to obtain allo-
cations per capita between €157–350. For 99% of PHCT,
modulator factor doesn’t represent an impact above +/−20%
over capitation factor. For each PHCT, ﬁnal allocation represents
an increase between 2%-6.25% on pharmaceutical expenditure
of 2005. CONCLUSION: The model leaves behind historical
models of growth, and establishes a high degree of responsibil-
ity to PHCTs in relation to pharmaceutical expenditure.
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OBJECTIVES: Diagnostic x-ray procedures using contrast
imaging agents especially in CT are on the rise. Typically con-
trast media are available in glass bottles and associated with a
number of potential problems including increased risk of injury,
costs of waste disposal, lost revenue, and disturbances in depart-
ment routines. A model was developed to estimate the annual
ﬁnancial and safety impact of switching glass to a polymer con-
tainer for a typical radiology department. METHODS: The
model was developed using results from a multi-European
market survey of radiology technologists on rates of technolo-
gists’ injuries from glass and/or metal crimps and from bottle
breaks. Survey results were conﬁrmed by a radiology department
head from a UK community hospital. In addition, disposal costs
for waste, acquisition cost of contrast media, utilization patterns
of media, procedure rates, technologist salaries, and cost of dis-
turbed department routine were incorporated in the ﬁnal budget
comparison. RESULTS: For a typical community hospital in the
UK conducting 56 procedures per shift, there is a potential to
waste approximately 200 manpower hours for clean-up of glass
breaks, injury care, and setting up additional contrast imaging
sets. This is associated with annual revenue loss to a department.
Budgetary gains are noted in lower disposal costs for polymer
bottles as they are lighter in weight. Signiﬁcantly more disposal
costs gains would be noted with the implementation of separat-
ing hazardous from regular waste. PLUSPAK, a polymer bottle
containing iohexol, a low osmolar contrast medium, has the
potential to save a radiology department considerable savings
due to cost-offsets associated with lower injury rates, product
wastage, disposal waste costs and faster departmental efﬁcien-
cies. CONCLUSIONS: Improvements in radiology technologist
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safety and departmental efﬁciencies can be realized with a glass
to polymer bottle conversion.
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OBJECTIVES: To analyze and evalue the economic impact of
cost of stored medicines at home. METHODS: The population
to investigating is constituted by 146,396 homes. The size mues-
tral calculated was 196 homes (alpha error = 0,05; conﬁdence
level 95%). The studied variables were: n persons who compose
the home; n 65 years older; n of stored medicines and classes;
sociocultural level; symptoms of disease in 15 days before the
interview; n of persons with chronic disease and type; etc. The
statistical analysis was made by the SPSS package. For quanti-
tative: mean, DS, IC95%; for qualitative: proportions. For the
analysis multivariante Student’s T-test for quantitative variables
and test of Chi-square for the qualitative ones. For the calcula-
tion of the cost of medicines stored in the homes one has con-
sidered 2 values: the cost of the found medication (price sales)
and the real value of this medication (considering the amount of
present medicine in the package at the moment of the interview).
RESULTS: The total number of polled homes was of 360. The
members average for home was of 3.9 (IC95% 3.8–4,0). The
total of found pharmaceutical specialities was 8.544, of them
61% was ﬁnanced by the NHS, and of ﬁnanced ones 26.5% and
12.6% they were not bought with and without medical pre-
scription, respectively. The average value for pharmaceutical spe-
cialities stored was €130.5/home (IC95%: 121.48–139.48).
CONCLUSIONS: A high percentage of medication exists stored
(12.6%) that in spite of needing medical prescription did not
have it. The self medication increases with the level of studies.
Almost 75% of the stored medication was not used by any
member of the home, and almost 11% they were expired medi-
cines. The total cost of medicines stored in our city can range
between €11–13 million (10% of the whole of expense in med-
icines in Malaga).
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OBJECTIVES: As part of the UK Government priorities to
improve access for people in primary care, the ‘Pharmacy First
Minor Ailments’ scheme was introduced by Nottingham City
Primary Care Trust in December 2003. People can ask for the
service, covering 12 minor ailments, at any participating phar-
macy and those who are exempt from NHS prescription charges
can receive the scheme’s formulary medicines free of charge. This
study aimed to measure the users’ satisfaction with the scheme.
METHODS: Questionnaires were distributed to scheme users
between May and December 2005. Satisfaction was measured
using ﬁve-point Likert scales for 24 items across eight dimen-
sions: general satisfaction, access/convenience, quality of drug,
physical environment, pharmacist’s competence, communica-
tion, interpersonal aspect and time spent with pharmacist. 
Individual dimension and overall satisfaction scores for each
respondent was calculated by summing the appropriate individ-
ual items scores. RESULTS: A total of 143 questionnaires were
completed (response rate 14%). Most respondents were white
women and the mean age was 33 years (range 17–62). Approx-
imately half of respondents had annual household income below
10,000 GBP. Most respondents were not economically active
with 36% looking after family and 25% unemployed. The mean
satisfaction score was 99.7 (SD 11.4, range 67–120, possible
score 24–120). The highest satisfaction score was reported for
access/convenience dimension and the lowest satisfaction with
the physical environment. Comparisons of overall satisfaction
scores did not demonstrate signiﬁcant differences with regard to
gender, age, ethnicity, educational level, employment and fre-
quency of using the service. However, those with a lower income
had signiﬁcantly higher overall satisfaction scores (ANOVA, F =
3.272, p = 0.042). CONCLUSIONS: Findings demonstrated a
high level of satisfaction with the ‘Pharmacy First Minor Ail-
ments’ scheme, particularly for those with lower incomes. Thus
the scheme can be seen as a successful way of improving access
to primary care in Nottingham City PCT.
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OBJECTIVES: Needle punctures are an occupational hazard for
health care workers and others. This analysis was performed to
assess use and associated costs of Emergency Department (ED)
care for work-related needle punctures. METHODS: 2001–2003
statewide Massachusetts ED visit databases were analyzed.
Work-related needle punctures were identiﬁed using diagnosis
codes, E-code 920.5 (accidental cutting/ piercing with hypoder-
mic needle) and a primary payer code indicating workmen’s com-
pensation. Cost estimates (2006 US$) include facility, ancillary
and physician services. ED charges were adjusted using 0.55
cost-to-charge ratio, appropriate inﬂation indices and geographic
factors to reﬂect U.S. national values. RESULTS: Over the three
years, 5288 ED visits for accidental needle punctures were iden-
tiﬁed. Of those, 3742 (71%) were work-related (annual visits:
2001 = 1171; 2002 = 1262; 2003 = 1309). Mean age was 38
years (median: 37, range: 16–77); 75% were female. Superﬁcial
injuries accounted for 9%; 81% were coded as ﬁnger/hand/arm
wound or injury; 4% other injuries and 5% reﬂected an admin-
istrative encounter. No hospitalizations or deaths occurred.
Almost all (98%) patients were treated and released with 2%
leaving against medical advice or disposition unknown. Average
visit duration was 1.6 hours (median: 1.2) at an average visit
cost of $319 (median: $255). On average, 1699 ED hours were
utilized per year. The average total cost per year for all work-
related needle puncture visits was $418,450 with a cumulative
three year cost of roughly $840,000. CONCLUSIONS: The ED
is utilized as a primary treatment center for work-related needle
punctures, even when the injury is superﬁcial or visit occurs as
part of the administrative process. Although the risk of con-
tracting a blood-borne virus and related patient anxiety need to
be addressed when such an injury occurs, an alternative, less
resource intensive location for evaluating these injuries should
be considered, particularly in high risk areas, such as hospitals,
given ED time and cost consequences.
